Why is "Apotex" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-07-12 13:10:34
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Apotex entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-07-12 and was most recently seen on 2026-07-12.
Wikipedia Overview
Apotex Inc. is a Canadian pharmaceutical corporation. Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$2.5 billion. By 2023, Apotex employed close to 8,000 people as Canada's largest drug manufacturer, with over 300 products selling in over 115 countries. Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infections and blood pressure.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Apotex Announces First Quarter 2027 Results - PR Newswire Canada
-
Apotex a ‘standout’ stock since IPO despite Trump tariff threat, analysts say - The Globe and Mail
-
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - PR Newswire
-
Global HR leadership means being a business leader first: Apotex CHRO - hcamag.com
-
Apotex Health (TSX:APTX) Stock Valuation Check As P/E Premium Conflicts With DCF Discount - Yahoo Finance
-
Apotex posts loss in first quarter after going public - BNN Bloomberg
-
Apotex Health (TSX:APTX) Stock Hit By Revenue Drop And Profit Reversal - simplywall.st
-
Earnings call transcript: Apotex posts solid Q1 2026 start as semaglutide boosts growth - Investing.com
-
Apotex Shares Rally as Trading Begins Following Pricing of C$1.3 Billion IPO - WSJ
-
Apotex Health shares jump in largest Toronto stock market IPO since 2021 - Reuters
-
Cumberland Pharmaceuticals posts $4.1 million Q2 loss after Apotex deal - Quiver Quantitative
-
Apotex Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
-
Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management - PR Newswire
-
Toronto Stock Exchange Welcomes Apotex - Yahoo Finance
-
Apotex Health seeks to raise up to C$1.2 billion, potentially reviving Toronto IPO market - Reuters
-
Apotex expands U.S. hospital portfolio with launch of generic Infuvite® Adult and Pediatric Injection - PR Newswire
-
Apotex expands ophthalmic portfolio with Health Canada approval of IHEEZO™ - PR Newswire
-
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada - PR Newswire
-
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic® - PR Newswire
-
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses - PR Newswire
-
APOTEX HEALTH CORP. FILES FINAL PROSPECTUS AND ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING - Yahoo Finance
-
Apotex reports $38M net loss in first quarter after going public in June - Toronto Star
-
APOTEX HEALTH CORP. UPSIZES ITS INITIAL PUBLIC OFFERING - Yahoo Finance
-
Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry - Reuters
-
Apotex Q1 FY27 slides: strong start post-IPO, Canadian growth shines - Investing.com
-
Canadian health firm Apotex prices IPO at top end, raising C$1.3 billion - Reuters
-
Apotex reports $38-million net loss in first quarter after going public in June - The Globe and Mail
-
Analysts bullish on Apotex as they initiate coverage following Canadian drugmaker's IPO - Financial Post
-
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan - Yahoo Finance
-
Brian Madden's Top Picks: Booking Holdings, Alimentation Couche-Tard & Apotex Health - BNN Bloomberg
-
Canadian health firm Apotex prices IPO at top end, raising C$1.3 billion - Yahoo Finance
-
Apotex Health Corp. (APTX) Opens the Market - TMX Newsfile
-
Apotex announces leadership changes - PR Newswire
-
Apotex Announces Strategic U.S. Sterile Filling Partnership with Halo Pharmaceuticals - PR Newswire
-
Cumberland to sell drug portfolio to Apotex for $100m - Pharmaceutical Technology
-
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex - Yahoo Finance
-
Apotex Launches $1 Billion Initial Public Offering - Pulse 2.0
-
Apotex Health files preliminary prospectus for initial public offering of shares - Yahoo! Finance Canada
-
Apotex Completes Strategic Transaction With Cumberland Pharmaceuticals - Pulse 2.0
-
Apotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular - PR Newswire
-
Apotex Gets Health Canada Approval for Generic Semaglutide - The Clinical Trial Vanguard
-
Apotex secures investment grade rating, amends credit facility By Investing.com - Investing.com
-
Apotex Strengthens Osteoporosis Care in Canada with Health Canada's Approval of DENOZA™, a Denosumab Biosimilar - PR Newswire
-
Apotex CEO says IPO provides greater growth potential despite more scrutiny - BNN Bloomberg
-
TMX Group Grows Index Reach As Record Apotex IPO Lifts TSX - Yahoo Finance
-
TSX hits three-week low on rising Mideast tensions; Apotex makes market debut - Reuters
-
Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement - PR Newswire Canada
-
Canada’s Apotex Reports Net Loss After Going Public - The Globe and Mail
-
Cumberland Pharmaceuticals closes $100 million sale of drug portfolio - The Business Journals
-
Apotex Expands Diabetes Portfolio With Generic Ozempic - Mexico Business News
-
APOTEX HEALTH CORP. FILES PRELIMINARY PROSPECTUS FOR INITIAL PUBLIC OFFERING - PR Newswire Canada
-
Apotex Shares Drop as Trump Tariff Threat Targets Overseas-Made Generic Drugs - Moomoo
-
Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026 - TradingView
-
Apotex Health Corp. Price Target Announced at C$43.00/Share by RBC Capital - Moomoo
-
Toronto Stock Exchange Welcomes Apotex - TradingView
-
Apotex expands ophthalmic portfolio with Health Canada approval of IHEEZO™ - Yahoo! Finance Canada
-
Apotex Announces First Quarter 2027 Results - The Globe and Mail
-
Apotex Health (TSX:APTX) Stock Could Be 51.7% Below Fair Value After Its IPO - simplywall.st
-
Apotex’s Generic Ozempic® (Semaglutide) Secures First FDA Tentative Approval - Pearce IP
-
Apotex Announces FDA Approval of Generic Infuvite® Pediatric Injection, Eligible for 180‑day CGT Exclusivity (Single‑Dose Vial), Complementing its Recent Approval of Generic Infuvite Adult Injection - PR Newswire
-
Canada’s Apotex Health Files To Hold IPO - TradingView
-
Apotex Health Trades 26.99cad, IPO at 24cad - Investing.com
-
Apotex Health, Greenfire Resources, Lundin Gold - TradingView
-
Apotex Health Prices Upsized IPO Of 54.17 Million Shares At C$24/Share For C$1.3 Billion - TradingView
-
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex - Yahoo Finance
-
Cumberland sells branded U.S. drugs to Apotex for $100M - Stock Titan
-
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - Eastern Progress
-
Apotex Health shares jump 17% in Toronto market debut - Investing.com
-
Why Apotex Health (TSX:APTX) Is Up 7.1% After First Generic Semaglutide Approval In Canada - simplywall.st
-
Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson
-
FDA Gives Tentative Approval of ANDA for Generic Semaglutide Injection - HCPLive
-
Apotex inks strategic transaction with Cumberland Pharma - The Pharma Letter
-
TSX tracks resource shares lower ahead of Apotex IPO - Reuters
-
Apotex obtains FDA OK for generic Infuvite - Drug Store News
-
Apotex emerges as only supplier of generic Ozempic in Canada for now - The Globe and Mail
-
Apotex Health Faces U.S. Sales Pressure as APTX Investors Weigh the Recovery Path - kalkine.ca
-
Apotex Secures First Canadian-Approved Generic Semaglutide for Weight Loss - Pearce IP
-
Canada Approves Apotex's Bid to Sell Generic Version of Wegovy - Moomoo
-
Apotex launches $1 billion IPO - Investing.com
-
Apotex Health Corp. Initiated at Buy by Desjardins Securities - Moomoo
-
Apotex obtains Health Canada’s approval for generic Ozempic - Drug Store News
-
APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED INITIAL PUBLIC OFFERING AND EXERCISE OF OVER-ALLOTMENT OPTION IN FULL - PR Newswire Canada
-
Apotex posts loss in first quarter after going public - CTV News
-
Halo Pharmaceuticals and Apotex announce strategic U.S. sterile filling partnership - ROI-NJ
-
Apotex Aims For Over C$1bn As It Launches IPO - insights.citeline.com
-
Apotex launches generic Infuvite adult, pediatric injections - Drug Store News
-
Apotex, Backers Raise $932 Million in Canada IPO Priced at Top - Bloomberg.com
-
Apotex posts loss in first quarter after going public - CP24
-
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - Financial Times
-
Health Canada approves 2nd generic version of Ozempic — and it's Canadian - CBC
-
Cumberland Pharmaceuticals (CPIX) jumps on $100 million Apotex asset-sale deal | CPIX Stock News - Quiver Quantitative
-
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada's Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%) - PR Newswire
-
1st generic semaglutide injection for weight loss approved: Health Canada - CBC
-
Apotex CEO says IPO provides greater growth potential despite more scrutiny - CityNews Halifax
-
Apotex raising IPO size to $1.3-billion on strong investor demand, source says - The Globe and Mail
-
Apotex & Dr Reddy’s Launch Generic Semaglutide in Canada - Pearce IP
-
Cumberland sells branded drug portfolio to Apotex for $100m - Investing.com
-
Cumberland closes $100M deal with Apotex, shifts focus to rare disease drug development. - Pluang
-
DifGen Pharmaceuticals LLC, in Collaboration with Apotex Inc., Announces FDA Approval of Generic Nintedanib Soft Gel Capsules, 100 mg and 150mg Therapeutically Equivalent to Ofev® - Yahoo Finance
-
Desjardins says Apotex Health is a buy - Cantech Letter
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.